CANCER AWARENESS NETWORK FOR IMMIGRANT MINORITY POPULATI

我们建议在纽约大都市区建立移民少数族裔人口癌症意识网络(CANIMP)，以增加纽约外国出生的少数族裔社区的癌症控制活动和获得临床试验的机会。这将通过纽约大学医学院两项主要倡议的联系来实现：(A)初级保健司的纽约移民健康特别工作组(NYTFIH)和(B)国家癌症研究所指定的卡普兰综合癌症中心(KCCC)。代表五个移民群体(海地人、拉美人、加勒比人、韩国人和中国人)的社区组织将成为该项目的合作伙伴。这一多样化的群体将能够进行独特的比较研究和协调一致的外联活动。其他网络合作伙伴将包括癌症预防和筛查项目，如乳房健康伙伴关系和ACS中文单位、纪念斯隆·凯特林医院的NCI-CIS、国土安全部少数民族健康办公室和纽约市社区卫生诊所。在第一阶段访谈中，将在五个移民群体中进行肺癌、前列腺癌、乳腺癌和宫颈癌的焦点小组和圆桌会议。在第二阶段，初级科学家将与KCCC现有的研究人员合作，开发试点癌症研究项目。这些项目将在第三阶段发展为同行评审的竞争性提案。CANIMP的双语工作人员将提供癌症社区教育、种族提供者临床试验教育、审查书面材料、提供口译服务，并为多语言信息热线提供工作人员。该项目将通过年度患者调查、第3年和第5年的提供者调查以及不同的过程和结果指标进行评估，例如少数族裔被纳入临床试验的百分比和少数族裔初级科学家开发试点项目的数量。

We propose the establishment of a Cancer Awareness Network for Immigrant Minority Populations (CANIMP) in the NY metropolitan area to increase cancer control activities and access to clinical trials in NY's foreign-born minority community. This will be achieved through the linkage of two major initiatives at NYU School of Medicine: (a) the New York Task Force on Immigrant Health (NYTFIH), Division of Primary Care, and (b) the NCI- designated Kaplan Comprehensive Cancer Center (KCCC). Community based organizations representing five immigrant groups (Haitian, Latino, ES-Caribbean, Korean, and Chinese) will be partners in this project. This diverse group will allow to conduct unique comparative research and coordinated outreach. Other network partners will include cancer prevention and screening programs such as the Breast Health Partnership and ACS Chinese Unit, NCI- CIS at Memorial Sloan Kettering, DHHS Office of Minority Health and NYC community health clinics. In Phase I interviews, focus groups, and roundtables on lung, prostate, breast, and cervical cancer will be conducted in five immigrant groups. In Phase II junior scientists will be partnered with established KCCC researchers to develop pilot cancer research projects. These projects will develop into peer- reviewed competitive proposals in Phase III. Bilingual CANIMP staff will provide cancer community education, ethnic provider education on clinical trials, review written materials, provide interpreter services, and staff a multilingual information line. The project will be evaluated through an annual patient survey, a provider survey in years 3 and 5, and through diverse process and outcome indicators such as percentage of minorities recruited into clinical trials and number of minority junior scientists developing pilot projects.